| License: Creative Commons Attribution 4.0 PDF - Published Version (7MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-433666
- DOI to cite this document:
- 10.5283/epub.43366
Abstract
Poor drug availability in the tissue of interest is a frequent cause of therapy failure. While nanotechnology has developed a plethora of nanocarriers for drug transport, their ability to unequivocally identify cells of interest remains moderate. Viruses are the ideal nanosized carriers as they are able to address their embedded nucleic acids with high specificity to their host cells. Here, it is ...
Owner only: item control page